Anaphylactic Reaction to Pemetrexed: A Case Report

Bibliographic Details
Title: Anaphylactic Reaction to Pemetrexed: A Case Report
Authors: Heloise Capelle, Joelle Birnbaum, Pascale Tomasini, Céline Tummino, Marion Gouitaa, Nathalie Ausias, Denis Charpin, Fabrice Barlesi, Marc Montana
Source: Journal of Pharmacy & Pharmaceutical Sciences, Vol 17, Iss 2 (2014)
Publisher Information: Frontiers Media S.A., 2014.
Publication Year: 2014
Collection: LCC:Therapeutics. Pharmacology
LCC:Pharmacy and materia medica
Subject Terms: Therapeutics. Pharmacology, RM1-950, Pharmacy and materia medica, RS1-441
More Details: Pemetrexed is approved to treat non-small cell lung cancer and has an overall favorable toxicity profile. We describe a 58-year-old man who developped an anaphylactic shock within few minutes from the beginning of pemetrexed perfusion. Pemetrexed was discontinued and the patient’s symptoms gradually resolved with administration of symptomatic treatment. Serum tryptase level remained normal and intra dermal skin tests were negative eventhough a nonspecific papule was noted. This case suggests that caution should be exercised when prescribing pemetrexed and clinicians must be warranted for the possibility of serious adverse events associated with pemetrexed use. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1482-1826
Relation: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/21453; https://doaj.org/toc/1482-1826
DOI: 10.18433/J32C8D
Access URL: https://doaj.org/article/ab7f921a790d4d6993bb4ae494607f4e
Accession Number: edsdoj.b7f921a790d4d6993bb4ae494607f4e
Database: Directory of Open Access Journals
More Details
ISSN:14821826
DOI:10.18433/J32C8D
Published in:Journal of Pharmacy & Pharmaceutical Sciences
Language:English